VERTEX PHARMACEUTICALS INC / MA Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation

VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $115.00 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-01.

Discontinued › Notes › Compensation Related Costs

us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2013-03-01

VERTEX PHARMACEUTICALS INC / MA adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2012 was $115.00M, a 0.88% increase from fiscal 2011.
VERTEX PHARMACEUTICALS INC / MA adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2011 was $114.00M, a 1.79% increase from fiscal 2010.
VERTEX PHARMACEUTICALS INC / MA adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2010 was $112.00M.

Period end	Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month
2012-12-31	$115.00M 10-K · filed 2013-03-01
2011-12-31	$114.00M 10-K · filed 2012-02-22
2010-12-31	$112.00M 10-K · filed 2011-02-17

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BRISTOL MYERS SQUIBB CO (BMY)	United States	$125.637B	12.67
PFIZER INC (PFE)	United States	$162.042B	31.94
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64